Literature DB >> 3771958

Estimation of theophylline absorption rate by means of the Wagner-Nelson equation.

J G Wagner.   

Abstract

The elimination rate constant of theophylline to be used in calculating the cumulative amount absorbed per milliliter of the volume of distribution is estimated from terminal theophylline concentrations of the same data set as that analyzed for absorption kinetics. Erroneous results are obtained if the elimination rate constant is obtained from a different treatment such as an oral solution or elixir or from intravenous data, and/or if the wrong asymptotic value is used. So-called "trickle absorption" is shown to be an artifact. Published data indicate appreciable intrasubject variation in the elimination rate constant of theophylline.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771958     DOI: 10.1016/0091-6749(86)90046-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

2.  Effects of variation in drug elimination on five methods for assessing zero-order drug absorption rates.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

3.  The influence of assay variability on pharmacokinetic parameter estimation.

Authors:  D A Graves; C S Locke; K T Muir; R P Miller
Journal:  J Pharmacokinet Biopharm       Date:  1989-10

4.  IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress.

Authors:  Valentyn Mohylyuk; Seyedreza Goldoozian; Gavin P Andrews; Andriy Dashevskiy
Journal:  Pharm Res       Date:  2020-10-22       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.